Melanotan-(1) “afamelanotide / Scenesse” – BBC report 2003 – photoprotective / tanning drug

Published October 18, 2010

Melanotan-(1) “afamelanotide / Scenesse” is reported on by the BBC’s Michael Peschardt who explains it as a melanin increasing photoprotective / tanning treatment being developed in Australia that will potentially help avoid skin cancers. Original Story Links: BBC Website Accompanying Web Page: news.bbc.co.uk Original Video (Real Player Format): news.bbc.co.uk Clinuvel (formerly Epitan), the company developing Melanotan-(1) as a bioabsorbable subcutaneous implant under the name “Scenesse / afamelanotide” (formerly CUV1647): www.clinuvel.com clinuvel.com Wikipedia article on the melanotan-(1) “afamelanotide” peptide: en.wikipedia.org Melanotan peptides information / discussion site: melanotan.org “Scenesse” is a registered trademark brand name of Clinuvel Pharmaceuticals Ltd. afamelanotide [Nle4, D-Phe7]α-MSH Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 synthetic melanocortin alpha Melanocyte-Stimulating Hormone α-Melanocyte-Stimulating Hormone NDP-MSH α-MSH a-MSH alpha-MSH
Video Rating: 4 / 5